Abstract
Despite chemotherapy regimens for advanced gastric cancer keep emerging,the patients still have poor prognosis.Molecular targeted therapy is another important direction for the treatment of advanced gastric cancer.Various drugs for molecular targeted therapy have been developed targeting epidermal growth factor receptor(EGFR),human epidermal growth factor receptor-2(HER-2),vascular endothelial growth factor(VEGF)and its receptor(VEGFR),and cyclooxygenase-2(COX-2);a number ofⅡ/Ⅲclinical trial have been completed or being conducted.The aim of this review is to summarize the recent progress on molecular targeted therapy for gastric cancer.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Academic Journal of Second Military Medical University
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
